RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
RxSight, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.69+0.18 (+3.99%)
Close on Oct 19, 2026
- Market cap
- $194.59M
- P/E (TTM)
- –
- Dividend yield
- –
RxSight, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAL | $105.40M | $107.91M | $108.06M | $108.41M | $106.95M | $103.77M | $96.50M | $85.76M | $75.03M | $63.61M | $54.09M | $45.29M | 82.6% | -1.4% |
| L D D | $9.84M | $13.63M | $20.67M | $28.37M | $35.33M | $40.38M | $39.70M | $39.00M | $36.80M | $34.33M | $32.09M | $28.70M | 7.7% | -72.2% |
| Service Warranty Service Contracts And Accessories | $5.84M | $5.94M | $5.75M | $5.31M | $4.79M | $4.16M | $3.73M | $3.54M | $3.35M | $3.16M | $2.89M | $2.59M | 4.6% | +22.0% |
By region
From the segment and revenue-disaggregation notes of RxSight's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.